Psychiatric Consultation Through Videoconference in a Primary Care Setting

NCT ID: NCT00298961

Last Updated: 2008-05-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

160 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-05-31

Study Completion Date

2007-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In our study we will aim to examine the issues of cost analysis, quality of life, clinical efficacy and satisfaction of psychiatric consultations through videoconference in a primary care setting in comparison with in-person psychiatric treatment and primary care only. The main hypotheses of the study are: Satisfaction of the patients will increase, the use of telepsychiatry will reduce the costs for the primary and mental health care centers as well as for the patients, the treatment will be as effective as in-person treatment, the number of patients referred to mental health treatment will be higher than that of the previous year, quality of life will improve and that there will be a stigma reduction of mental illness.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Telepsychiatry, as a method which utilizes videoconferencing as a means for consultation, examination and treatment of patients as a substitute for in-person treatment has been in use now for over 40 years. With telepsychiatry there is an attempt to deal with the issues of providing service to patients who reside at a considerable distance from the mental health facilities or that conversely do not call for mental health services for other diverse reasons such as loss of work days, social stigma, travel expenses and so forth.

In Israel, mental health services are provided to 1.5% of the population whereas the incidence in other developed countries is significantly higher, reaching 3-5%, while the prevalence of mental illness in Israel is similar. One can hypothesize that the above factors such as social stigma, mental health care availability, loss of work days and travel expenses all play a role in this. Consequently, patients may prefer to see their primary care physician as an alternative, and according to reports of the Israeli national health services, 30%-50% of visits to the primary care physician are mental health related. Thanks to the technological advances in telecommunications, especially regarding cost reduction and higher bandwidths, there has been a renewed interest in telepsychiatry. However, the issue of the cost effectiveness of telepsychiatry is still controversial. Out of 380 studies on telepsychiatry published from 1956 to 2002, only 12 dealt with the question of cost effectiveness, and among those the results were equivocal. Another question that has scarcely been studied is that of quality of life within telepsychiatry treatment. Finally, the issue of telepsychiatry that is used as a consultation tool in the aid of the primary physician that occurs physically in his own practice is another novel angle we wish to explore. The advantages embodied in this are potentially many - patient discreteness and confidentiality, decrease in expenses and stigma reduction among others.

In our study we will attempt to address the above issues that have not received the focus of attention in many of the published studies so far - cost analysis and quality of life within the context of telepsychiatry consultation in primary care. Additionally, we will address the issues of clinical efficacy and satisfaction (of the primary care provider as well as that of the patient) from the treatment.

Our study hypotheses are:

1. The satisfaction of the patients will increase during the 12 months of study in the group treated by telepsychiatry in comparison with the control groups.
2. Cost analysis - the use of telepsychiatry will reduce the costs for the primary health care centers and/or for the mental health centers: Travel expenses, a decrease in visitations to the primary health care center, a decrease in hospitalizations in general hospitals and/or psychiatric hospitals, a decrease in the number of ancillary tests and of lost work days.
3. Effectiveness of treatment - the mental and physical well being of the patients will improve or at least not be impaired in the group treated by telepsychiatry as compared to the control groups due to the increased availability of the consultation service.
4. The number of patients referred to mental health treatment will be higher than that of the previous year due to the increased availability of telepsychiatry within the primary care setting.
5. The patients will prefer the telepsychiatry service as compared to a referral to a mental health center.
6. Quality of life will improve or it least not be impaired in the group treated by telepsychiatry as compared to the control groups.
7. Stigma reduction - Visitations to the primary health care center as opposed to the mental health center will lower the possibility of the formation of a social stigma of mental disease.

Comparison Groups:

1. Telepsychiatry treated patients within the primary care setting.
2. In-person treated patients by a psychiatrist at the mental health center.
3. Primary care treated patients without a psychiatry consultation.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Remote Consultation Community Psychiatry

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Videoconference equipment FALCON/IP

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients referred by the primary care physician.
* Age 18 and over.
* Speak Hebrew.

Exclusion Criteria

* Patients that suffer from severe dementia.
* Patients suffering from addiction to drugs or alcohol.
* Patients who are deaf, dumb or blind.
* Patients who have a legal guardian.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Galil Center for Telemedicine and Medical Informatics

OTHER

Sponsor Role collaborator

Sha'ar Menashe Mental Health Center

OTHER

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mahmud Jabarin, MD

Role: PRINCIPAL_INVESTIGATOR

Sha'ar Menashe Mental Health Center, Israel

Ilan Modai, MD, MHA

Role: STUDY_CHAIR

Sha'ar Menashe Mental Health Center, Israel

Ehud Susser, MD

Role: STUDY_CHAIR

Sha'ar Menashe Mental Health Center, Israel

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sha'ar Menashe Mental Health Center Ambulatory Clinic

Hadera, , Israel

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Israel

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Mahmud Jabarin, MD

Role: CONTACT

Phone: +972-4-6278110

Email: [email protected]

Ehud Susser, MD

Role: CONTACT

Phone: +972-4-6278946

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Mahmud Jabarin, MD

Role: primary

Ehud Susser, MD

Role: backup

References

Explore related publications, articles, or registry entries linked to this study.

Hyler SE, Gangure DP, Batchelder ST. Can telepsychiatry replace in-person psychiatric assessments? A review and meta-analysis of comparison studies. CNS Spectr. 2005 May;10(5):403-13. doi: 10.1017/s109285290002277x.

Reference Type BACKGROUND
PMID: 15858458 (View on PubMed)

Frueh BC, Deitsch SE, Santos AB, Gold PB, Johnson MR, Meisler N, Magruder KM, Ballenger JC. Procedural and methodological issues in telepsychiatry research and program development. Psychiatr Serv. 2000 Dec;51(12):1522-7. doi: 10.1176/appi.ps.51.12.1522.

Reference Type BACKGROUND
PMID: 11097648 (View on PubMed)

Hilty DM, Luo JS, Morache C, Marcelo DA, Nesbitt TS. Telepsychiatry: an overview for psychiatrists. CNS Drugs. 2002;16(8):527-48. doi: 10.2165/00023210-200216080-00003.

Reference Type BACKGROUND
PMID: 12096934 (View on PubMed)

May C, Gask L, Atkinson T, Ellis N, Mair F, Esmail A. Resisting and promoting new technologies in clinical practice: the case of telepsychiatry. Soc Sci Med. 2001 Jun;52(12):1889-901. doi: 10.1016/s0277-9536(00)00305-1.

Reference Type BACKGROUND
PMID: 11352414 (View on PubMed)

Monnier J, Knapp RG, Frueh BC. Recent advances in telepsychiatry: an updated review. Psychiatr Serv. 2003 Dec;54(12):1604-9. doi: 10.1176/appi.ps.54.12.1604.

Reference Type BACKGROUND
PMID: 14645799 (View on PubMed)

Williams TL, May CR, Esmail A. Limitations of patient satisfaction studies in telehealthcare: a systematic review of the literature. Telemed J E Health. 2001 Winter;7(4):293-316. doi: 10.1089/15305620152814700.

Reference Type BACKGROUND
PMID: 11886667 (View on PubMed)

Roine R, Ohinmaa A, Hailey D. Assessing telemedicine: a systematic review of the literature. CMAJ. 2001 Sep 18;165(6):765-71.

Reference Type BACKGROUND
PMID: 11584564 (View on PubMed)

Simpson J, Doze S, Urness D, Hailey D, Jacobs P. Telepsychiatry as a routine service--the perspective of the patient. J Telemed Telecare. 2001;7(3):155-60. doi: 10.1258/1357633011936318.

Reference Type BACKGROUND
PMID: 11346475 (View on PubMed)

Yoshino A, Shigemura J, Kobayashi Y, Nomura S, Shishikura K, Den R, Wakisaka H, Kamata S, Ashida H. Telepsychiatry: assessment of televideo psychiatric interview reliability with present- and next-generation internet infrastructures. Acta Psychiatr Scand. 2001 Sep;104(3):223-6. doi: 10.1034/j.1600-0447.2001.00236.x.

Reference Type BACKGROUND
PMID: 11531660 (View on PubMed)

Dongier M, Tempier R, Lalinec-Michaud M, Meunier D. Telepsychiatry: psychiatric consultation through two-way television. A controlled study. Can J Psychiatry. 1986 Feb;31(1):32-4. doi: 10.1177/070674378603100107.

Reference Type BACKGROUND
PMID: 3512068 (View on PubMed)

Cruz M, Krupinski EA, Lopez AM, Weinstein RS. A review of the first five years of the University of Arizona telepsychiatry programme. J Telemed Telecare. 2005;11(5):234-9. doi: 10.1258/1357633054471821.

Reference Type BACKGROUND
PMID: 16035965 (View on PubMed)

Hyler SE, Gangure DP. A review of the costs of telepsychiatry. Psychiatr Serv. 2003 Jul;54(7):976-80. doi: 10.1176/appi.ps.54.7.976.

Reference Type BACKGROUND
PMID: 12851433 (View on PubMed)

Krupinski EA, Barker G, Lopez AM, Weinstein RS. An analysis of unsuccessful teleconsultations. J Telemed Telecare. 2004;10(1):6-10. doi: 10.1258/135763304322764112.

Reference Type BACKGROUND
PMID: 15006208 (View on PubMed)

Hilty DM, Marks SL, Urness D, Yellowlees PM, Nesbitt TS. Clinical and educational telepsychiatry applications: a review. Can J Psychiatry. 2004 Jan;49(1):12-23. doi: 10.1177/070674370404900103.

Reference Type BACKGROUND
PMID: 14763673 (View on PubMed)

Kennedy C, Yellowlees P. A community-based approach to evaluation of health outcomes and costs for telepsychiatry in a rural population: preliminary results. J Telemed Telecare. 2000;6 Suppl 1:S155-7. doi: 10.1258/1357633001934492.

Reference Type BACKGROUND
PMID: 10794004 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TelepsychiatryCTIL

Identifier Type: -

Identifier Source: org_study_id